William M. Duck*, Jeremy Sobel*, Janet M. Pruckler*, Qunsheng Song*, David Swerdlow*, Cindy Friedman*, Alana Sulka*, Balasubra Swaminathan*, Tom Taylor*, Mike Hoekstra*, Patricia M. Griffin*, Duane Smoot†, Rick Peek‡, DavidC. Metz§, Peter B. Bloom¶, Steven Goldschmid¶, Julie Parsonnet#, George Triadafilopoulos#, Guillermo I. Perez-Perez**, Nimish Vakil††, Peter Ernst‡‡, Steve Czinn§§, Donald Dunne§§, and Ben D. Gold*
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Howard University Medical Center, Washington, DC, USA; ‡Vanderbilt University Medical Center, Nashville, Tennessee, USA; §University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, USA; ¶Atlanta Veterans Affairs Medical Center, Atlanta, Georgia, USA; #Stanford University Medical Center, Palo Alto, California, USA; **New York University School of Medicine, New York, New York, USA; ††Sinai Samaritan Medical Center, Milwaukee, Wisconsin, USA; ‡‡University of Virginia, Charlottesville, Virginia, USA; §§University Hospitals of Cleveland, Cleveland, Ohio, USA; ¶¶Indiana University Medical Center, Indianapolis, Indiana, USA
Main Article
Table 1
Endoscopy findings on patients enrolled in the Helicobacter pylori Antimicrobial Resistance Monitoring Project, 1998–2002a
| Endoscopic diagnosis |
No. of patients (%) |
Stomach erosion
|
88 (27.0)
|
Gastritis
|
36 (11.0)
|
Duodenal ulcers
|
26 (8.0)
|
Esophagitis
|
26 (8.0)
|
Gastric ulcer
|
26 (8.0)
|
Duodenal erosion
|
24 (7.0)
|
Barrett esophagus
|
9 (3.0)
|
Nodularity
|
8 (2.0)
|
Stomach tumor
|
4 (1.0)
|
Bleedingb
|
1 (0.3)
|
| Other diagnosis |
27 (8.0) |
Main Article
Top of Page